Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com
Johnson & Johnson, AbbVie, Teva and Endo face $50B opioid trial, pharma's first since 2019 | Fierce Pharma
/cloudfront-us-east-1.images.arcpublishing.com/gray/WDNBKWZ2NFFGVHC3OWLHIXOFC4.jpg "State of W.Va. going to trial against J&J, other drugmakers in April")
State of W.Va. going to trial against J&J, other drugmakers in April
Johnson & Johnson Profited From Both Sides Of Opioid Crisis, Says Epidemic Expert | KGOU
Oklahoma takes on drugmakers J&J, Teva in landmark opioid trial | Reuters
Military commission of Captain Halbert S. Rogers - Andrew Johnson Collection - Tennessee Virtual Archive
Teva Pharmaceuticals - Wikipedia
J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California | BioSpace
Johnson & Johnson stock climbs as judge reduces opioid penalty to $465 million
Teva, J&J make multibillion-dollar settlement offers as opioid trial gets going | Fierce Pharma
Johnson & Johnson ordered to pay $572M for fuelling Oklahoma's opioid crisis | CBC News
Johnson & Johnson ordered to pay $572M for fuelling Oklahoma's opioid crisis | CBC News
Congressional resolution honoring former President Andrew Johnson upon his death - Andrew Johnson Collection - Tennessee Virtual Archive
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
State Reaches Settlement Agreement With Teva; Opioid Trial To Continue Against Johnson & Johnson
Johnson & Johnson, Teva, others face federal criminal probe into opioid sales: WSJ | Fierce Pharma
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
First Opioid Trial Takes Aim at Johnson & Johnson - The New York Times
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters
Senator, blocking subpoena of Teva, says matter should be left to courts
OTC Anti-Infective Drug Market Growth Status and Outlook 2023-2029 |Bayer, GSK, Teva, Johnson & Johnson
Conrad Johnson - Senior Director, Legal Counsel - Teva Pharmaceuticals | LinkedIn
Johnson & Johnson et al: Rumored $100B Opioid Settlement Could Upend Pain Management Companies (NYSE:JNJ) | Seeking Alpha
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Johnson & Johnson, AbbVie, Teva and Endo score industry's first opioid trial win | Fierce Pharma
